SCHEMBL7932074

SCHEMBL7932074

Cc1ccc(S(=O)(=O)/C=C/C(F)(F)F)cc1

nearest known ligand 0.73

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TLR9 Q9NR96 1/20 0.73
ALDH1A1 P00352 7/20 0.53
MAPT P10636 4/20 0.53
TDP1 Q9NUW8 4/20 0.53
CYP3A4 P08684 3/20 0.53
CYP2C9 P11712 3/20 0.53
CYP2C19 P33261 3/20 0.53
MEN1 O00255 3/20 0.53
KMT2A Q03164 3/20 0.53
HPGD P15428 3/20 0.53
NPC1 O15118 2/20 0.53
NFKB1 P19838 2/20 0.53
RAB9A P51151 2/20 0.53
TP53 P04637 2/20 0.53
CYP1A2 P05177 2/20 0.53
CYP2D6 P10635 2/20 0.53
MAPK1 P28482 2/20 0.53
HSD17B10 Q99714 2/20 0.53
S100A4 P26447 1/20 0.53
MTOR P42345 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2578234 0.85 TLR9 (1.00) TLR9ALDH1A1MAPTTDP1CYP3A4
SCHEMBL2578236 0.85 TLR9 (1.00) TLR9ALDH1A1MAPTTDP1CYP3A4
SCHEMBL11845111 0.81 TLR9 (0.45) TLR9ALDH1A1TDP1CYP3A4CYP2C9
SCHEMBL11845104 0.81 TLR9 (0.45) TLR9ALDH1A1TDP1CYP3A4CYP2C9
SCHEMBL571864 0.80 TLR9 (0.59) TLR9ALDH1A1TDP1CYP2C9CYP2C19
SCHEMBL571865 0.80 TLR9 (0.59) TLR9ALDH1A1TDP1CYP2C9CYP2C19
SCHEMBL2828908 0.80 TLR9 (0.59) TLR9ALDH1A1TDP1CYP2C9CYP2C19
SCHEMBL10826101 0.77 TLR9 (0.82) TLR9ALDH1A1MAPTTDP1CYP3A4
SCHEMBL10825882 0.77 TLR9 (0.82) TLR9ALDH1A1MAPTTDP1CYP3A4
SCHEMBL10600352 0.75 TLR9 (0.78) TLR9ALDH1A1MAPTTDP1CYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO disclosed